CAS 172733-08-3: Methyl 2-[[3-(2-amino-2-oxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]acetate
Formula:C22H22N2O5
InChI:InChI=1S/C22H22N2O5/c1-3-15-20(21(26)22(23)27)19-16(24(15)12-14-8-5-4-6-9-14)10-7-11-17(19)29-13-18(25)28-2/h4-11H,3,12-13H2,1-2H3,(H2,23,27)
InChI key:InChIKey=VJYDOJXJUCJUHL-UHFFFAOYSA-N
SMILES:O=C(N)C(=O)C=1C=2C(OCC(=O)OC)=CC=CC2N(C1CC)CC=3C=CC=CC3
- Synonyms:
- Acetic acid, 2-[[3-(2-amino-2-oxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]-, methyl ester
- LY 333013
- Acetic acid, [[3-(aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]-, methyl ester
- Varespladib methyl
- Methyl 2-[[3-(2-amino-2-oxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]acetate
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Varespladib methyl REF: 3D-XGA73308CAS: 172733-08-3 | Min. 95% | 147.00 €~799.00 € | Tue 15 Apr 25 |
![]() | Varespladib methyl REF: TM-T17218CAS: 172733-08-3 | 100% - 99.69% | 117.00 €~2,822.00 € | Tue 06 May 25 |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Varespladib methyl
Controlled ProductCAS:172733-08-3
Varespladib methyl is a secretory phospholipase A2 inhibitor that blocks the production of inflammatory lipids, …
Formula:
C22H22N2O5
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
394.42 g/mol
Ref: 3D-XGA73308
1mg | 147.00 € | ||
2mg | 186.00 € | ||
5mg | 334.00 € | ||
10mg | 489.00 € | ||
25mg | 799.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Varespladib methyl
CAS:172733-08-3
Varespladib methyl (LY333013), a bioavailable prodrug of Varespladib, is a selective group II secretory phospholipase …
Formula:
C22H22N2O5
Purity:
100% - 99.69%
Color and Shape:
Solid
Molecular weight:
394.42
Ref: TM-T17218
1mg | 117.00 € | ||
5mg | 283.00 € | ||
10mg | 454.00 € | ||
25mg | 750.00 € | ||
50mg | 1,026.00 € | ||
100mg | 1,406.00 € | ||
500mg | 2,822.00 € | ||
1mL*10mM (DMSO) | 423.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025